Hantz Financial Services’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.22M | Buy |
26,638
+11,336
| +74% | +$1.37M | 0.05% | 264 |
|
|
2025
Q1 | $1.71M | Sell |
15,302
-562
| -4% | -$62.7K | 0.03% | 350 |
|
|
2024
Q4 | $1.54M | Sell |
15,864
-370
| -2% | -$36K | 0.03% | 363 |
|
|
2024
Q3 | $1.87M | Buy |
16,234
+248
| +2% | +$28.5K | 0.03% | 353 |
|
|
2024
Q2 | $1.7M | Sell |
15,986
-8,401
| -34% | -$894K | 0.03% | 344 |
|
|
2024
Q1 | $2.36M | Sell |
24,387
-392
| -2% | -$37.9K | 0.05% | 318 |
|
|
2023
Q4 | $2.5M | Sell |
24,779
-1,303
| -5% | -$132K | 0.05% | 304 |
|
|
2023
Q3 | $2.66M | Sell |
26,082
-4,482
| -15% | -$457K | 0.07% | 272 |
|
|
2023
Q2 | $3.08M | Buy |
30,564
+1,218
| +4% | +$123K | 0.08% | 258 |
|
|
2023
Q1 | $2.7M | Buy |
29,346
+112
| +0.4% | +$10.3K | 0.07% | 258 |
|
|
2022
Q4 | $2.65M | Sell |
29,234
-1,913
| -6% | -$174K | 0.08% | 254 |
|
|
2022
Q3 | $2.37M | Buy |
31,147
+837
| +3% | +$63.6K | 0.08% | 255 |
|
|
2022
Q2 | $2.56M | Buy |
30,310
+1,547
| +5% | +$131K | 0.09% | 244 |
|
|
2022
Q1 | $2.52M | Buy |
28,763
+3,511
| +14% | +$308K | 0.07% | 248 |
|
|
2021
Q4 | $2.21M | Buy |
25,252
+4,898
| +24% | +$428K | 0.06% | 259 |
|
|
2021
Q3 | $1.67M | Buy |
20,354
+3,691
| +22% | +$302K | 0.05% | 275 |
|
|
2021
Q2 | $1.52M | Buy |
16,663
+4,162
| +33% | +$380K | 0.06% | 265 |
|
|
2021
Q1 | $1.07M | Buy |
12,501
+11,175
| +843% | +$956K | 0.04% | 276 |
|
|
2020
Q4 | $125K | Sell |
1,326
-2,108
| -61% | -$199K | 0.01% | 446 |
|
|
2020
Q3 | $299K | Buy |
3,434
+128
| +4% | +$11.1K | 0.02% | 347 |
|
|
2020
Q2 | $289K | Buy |
3,306
+780
| +31% | +$68.2K | 0.02% | 333 |
|
|
2020
Q1 | $208K | Buy |
+2,526
| New | +$208K | 0.01% | 345 |
|